Gary L. Cochran, Pharm.D., S.M.

Ethical and Regulatory Issues

Gary L. Cochran is an associate professor at the University of Nebraska Medical Center (UNMC). He received a B.S. degree in business administration from the University of Nebraska in 1991, a Pharm.D. degree from UNMC in 1997, and an M.S. degree in epidemiology from the Harvard School of Public Health in 2004. He completed a pharmacy practice residency and a pharmacoeconomics and outcomes research fellowship at UNMC in 1998 and 2000, respectively.

Cochran’s research objective is to improve the safety and quality of rural health care through advancing and disseminating knowledge that will affect both clinical care and health policy. His current research evaluates the effectiveness of medication use systems and health information technologies to improve health care safety and quality.

Michael E. Ernst, Pharm.D., FCCP, BCGP

Ethical and Regulatory Issues

Dr. Ernst is a Clinical Professor in the Department of Pharmacy Practice and Science at the University of Iowa College of Pharmacy, and in the Department of Family Medicine, Carver College of Medicine. He provides collaborative patient care in the Family Medicine clinic and in the UI Geriatric Assessment Clinic, and he is involved in the interdisciplinary education of students from the UI Colleges of Pharmacy and Medicine and medical residents and fellows in the Family Medicine training program. In 2016, Dr. Ernst was among the first group of pharmacists to achieve the Certified Hypertension Specialist designation. Dr. Ernst’s research focuses in hypertension, and geriatrics; since 2010 he has served on the core leadership team of the internationally-conducted ASPirin in Reducing Events in the Elderly (ASPREE) and ASPREE-eXTension (ASPREE-XT) studies.

Jacqueline McLaughlin, Ph.D., M.S.

Ethical and Regulatory Issues

Jacqueline McLaughlin received her B.S. degree in biological engineering from North Carolina State University, her M.S. degree in biomedical engineering from the University of Memphis, and her Ph.D. degree in educational research and policy analysis from North Carolina State University. She spent 1 year as a postdoctoral fellow with the Office of Strategic Planning and Assessment (OSPA) at the UNC Eshelman School of Pharmacy and currently serves the school as an associate professor of educational innovation and research and as the director of CIPhER (Center for innovative Pharmacy Education Research). McLaughlin has published more than 100 peer-reviewed papers about higher education and the health professions. She leads educational research about and across the continuum of education, including admissions, classroom engagement, experiential learning, and extracurricular activities.

McLaughlin is involved in educational research that examines relationships between student characteristics, engagement, and performance during a curriculum. Her research experience and interests extend across the context of admissions, classroom engagement, experiential learning, and extracurricular activities.

Daniela Moga, M.D., Ph.D.

Ethical and Regulatory Issues

Dr. Moga is an Associate Professor of Pharmacy Practice and Science, and Epidemiology at University of Kentucky. She currently serves as Larry H. Spears Endowed Chair in Pharmacogenetics and Assistant Dean for Research in the College of Pharmacy. Dr. Moga's areas of interest include geriatric pharmacoepidemiology and health outcomes research. Currently, her focus is on evaluating the use and health effects of potentially inappropriate medications by older adults with multiple comorbid conditions. In addition, Dr. Moga's research aims at developing interventions to deprescribe inappropriate medications and optimize treatment in older adults. Dr.Moga currently serves as PI for a large study evaluating the effect of a patient-centered medication therapy management team intervention aiming to bolster cognitive reserve by increasing medication appropriateness in older adults, “INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer’s Symptomatic Expression: The INCREASE study

Margie E. Snyder, Pharm.D., MPH, FCCP, FAPhA

Ethical and Regulatory Issues

Dr. Margie E. Snyder is a Professor of Pharmacy Practice at the Purdue University College of Pharmacy. Dr. Snyder completed her Doctor of Pharmacy, PGY-1 community pharmacy residency, Master of Public Health, and community practice research fellowship at the University of Pittsburgh. Her scholarship is focused on community pharmacist practice advancement. Her expertise is in collaboration with practice-based research networks (PBRNs) and the application of qualitative and mixed-methods. She founded and directs a community pharmacy PBRN (Rx-SafeNet). Dr. Snyder has been almost continuously federally funded since 2010, first receiving a KL2 award from the Indiana Clinical and Translational Sciences Institute, followed by K08, R21, and R18 awards from the Agency for Healthcare Research and Quality (AHRQ). Her total extramural funding support to date equals approximately $2.5 million as a Principal Investigator and she has published over 50 peer-reviewed journal articles. In 2021, she was appointed as a standing member to the NIH Organization and Delivery of Health Services study section for a 4-year term. She has also served as an ad hoc reviewer on several study sections for the NIH and AHRQ. Dr. Snyder has been active in ACCP for over 10 years and was recognized as a Fellow in 2017.

Diana M. Sobieraj, Pharm.D., FCCP, BCPS

Ethical and Regulatory Issues

Diana M. Sobieraj is an Associate Professor in the Department of Pharmacy Practice. She earned her Doctor of Pharmacy degree from the University of Rhode Island and subsequently completed a pharmacy practice residency at Hartford Hospital/University of Connecticut School of Pharmacy. Dr. Sobieraj’s scholarly interests focus on comparative effectiveness and health outcomes research where she has over 2.5 million dollars of funded research and more than 60 publications in the peer-reviewed literature, including journals such as JAMA, Annals of Internal Medicine and the Journal of the American Geriatrics Society. Her primary work is in systematic review and meta-analysis resulting in several publications that have served as the evidence base for clinical practice guideline development in the United States. Dr. Sobieraj’s research has been recognized and awarded the 2018 ACCP New Investigator Award and the 2019 ASHP Drug Research Literate Award. She is a preceptor in the UConn Health Outcomes Fellowship Program and for the PGY-1 Residency Program at Hartford Hospital where she serves as a research advisor and preceptor for an academic rotation. Diana also serves as a member of the UConn IRB.